Two members of Taiwan's main opposition Kuomintang (KMT) said Monday they will ask a court to revoke the emergency use authorization (EUA) granted to a locally developed COVID-19 vaccine candidate that has not started Phase III clinical trials.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Golden Horse Award wins by Chinese films garner praise for Taiwan
11/25/2024 05:14 PM - Society
3 sentenced for defrauding Navy of NT$82 million
11/25/2024 05:01 PM - Sports
Captain Taiwan: Chen Chieh-hsien and his glorious return to Japan
11/25/2024 04:24 PM - Business
U.S. dollar closes sharply lower on Taipei forex market
11/25/2024 04:23 PM - Business
Winning numbers for September-October uniform invoice lottery released
11/25/2024 03:55 PM